TapewireFind a company

person · Reporting owner

de Pesquidoux Hubert

Disclosed activity across 3 companies

Tapewire entity
56052
SEC CIK
0001464176

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Criteo S.A.CRTO · Entity 291DirectorNovember 22, 2024November 22, 2024
RADISYS CORPRSYS · Entity 161880DirectorDecember 07, 2017December 08, 2017
SEQUANS COMMUNICATIONSSQNS · Entity 7292DirectorMarch 25, 2026March 25, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Criteo S.A.

Report date November 22, 2024 · Filed November 22, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect50,631 Reported balance After 2024-11-22 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2024-11-22 · Grant · Acquired 4,750 · Balance 50,631

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.

F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Filing footnotes · ownership attribution and instrument terms

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.

F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

RADISYS CORP

Report date December 07, 2017 · Filed December 08, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect110,218 Reported balance After 2017-12-07 transaction · row 1
1 source row

Row 1 · 2017-12-07 · Exercise / conversion · Acquired 6,872 · Balance 110,218

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct13,743 Reported balance After 2017-12-07 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2017-12-07 · Exercise / conversion · Disposed 6,872 · Balance 13,743

F1: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2: N/A

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2: N/A

SEQUANS COMMUNICATIONS

Report date March 25, 2026 · Filed March 25, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.13 · Expires 2034-06-28DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.15 · Expires 2035-06-30DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.65 · Expires 2032-06-24DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $2.89 · Expires 2029-07-01DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $3.31 · Expires 2027-07-03DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.51 · Expires 2030-06-29DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.49 · Expires 2031-06-25DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.86 · Expires 2026-06-29DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.54 · Expires 2033-06-27DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $2.04 · Expires 2028-07-02DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-25 · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · Balance Not disclosed

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

Filing footnotes · ownership attribution and instrument terms

F1: Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 22, 2024 Filed Nov 22, 2024 16:09 UTC Criteo S.A. CRTO · Entity 291 GrantOrdinary Shares 4,750 $39.20 $186,200.00
Disclosure

SEC source: 0001576427-24-000136 · wk-form4_1732309732.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,631

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The Reporting Person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the Reporting Person.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
March 11, 2024 Filed Mar 12, 2024 16:13 UTC Criteo S.A. CRTO · Entity 291 GrantOrdinary Shares 6,000 $33.94 $203,640.00
Disclosure

SEC source: 0001576427-24-000033 · wk-form4_1710274413.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,881

F1 · security: The Ordinary shares may be represented by American Depository Shares, each of which represents one Ordinary share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 16:02 UTC Criteo S.A. CRTO · Entity 291 Exercise / conversionNon-employee Warrant (right to buy) · Derivative 10,200 $0.00 Strike: $10.34 $0.00
Disclosure

SEC source: 0001576427-23-000007 · wf-form4_167649493455472.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,200 shares

Expires 2023-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. Warrant is set to expire on March 6, 2023.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
February 13, 2023 Filed Feb 15, 2023 16:02 UTC Criteo S.A. CRTO · Entity 291 Exercise / conversionOrdinary Shares 10,200 $10.34 $105,468.00
Disclosure

SEC source: 0001576427-23-000007 · wf-form4_167649493455472.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.34 using the exchange rate as of February 13, 2023 (1.00 = $0.933).

F3 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
December 02, 2022 Filed Dec 2, 2022 16:10 UTC Criteo S.A. CRTO · Entity 291 GrantOrdinary Shares 7,632 $26.90 $205,300.80
Disclosure

SEC source: 0001576427-22-000118 · wf-form4_167001539890750.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,681

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person.

F3 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.86 to $26.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4 · balance_after: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
October 21, 2022 Filed Oct 25, 2022 16:09 UTC Criteo S.A. CRTO · Entity 291 Exercise / conversionNon-employee Warrant (right to buy) · Derivative 10,400 $0.00 Strike: $8.13 $0.00
Disclosure

SEC source: 0001576427-22-000087 · wf-form4_166672854460256.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,400 shares

Expires 2022-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $8.13 using the exchange rate as of October 21, 2022 (1.00 = $0.983).

F4 · derivative.exercise_date: Warrant granted on October 25, 2012. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
October 21, 2022 Filed Oct 25, 2022 16:09 UTC Criteo S.A. CRTO · Entity 291 Exercise / conversionOrdinary Shares 10,400 $8.13 $84,552.00
Disclosure

SEC source: 0001576427-22-000087 · wf-form4_166672854460256.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $8.13 using the exchange rate as of October 21, 2022 (1.00 = $0.983).

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
December 17, 2021 Filed Dec 20, 2021 16:10 UTC Criteo S.A. CRTO · Entity 291 GrantOrdinary Shares 3,857 $40.46 $156,060.78
Disclosure

SEC source: 0001576427-21-000082 · wf-form4_164003461375133.xml · nonDerivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,649

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person.

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
December 17, 2021 Filed Dec 20, 2021 16:10 UTC Criteo S.A. CRTO · Entity 291 GrantOrdinary Shares 492 $39.30 $19,334.27
Disclosure

SEC source: 0001576427-21-000082 · wf-form4_164003461375133.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,792

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person.

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
November 30, 2020 Filed Dec 2, 2020 16:05 UTC Criteo S.A. CRTO · Entity 291 GrantOrdinary Shares 7,300 $19.06 $139,108.80
Disclosure

SEC source: 0001576427-20-000114 · wf-form4_160694311554416.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,300

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · kind: The reporting person purchased these securities in accordance with a compensation plan between the Issuer and members of its Board of Directors. As part of its independent director compensation program, the Issuer annually pays additional remuneration to its non-employee directors to facilitate their investment in Company securities. This additional remuneration must be used by the recipient, within a certain period of time, to purchase Issuer securities on the open market. These securities are subject to a time-based shareholding commitment agreed to by the reporting person.

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
October 24, 2019 Filed Oct 28, 2019 16:06 UTC Criteo S.A. CRTO · Entity 291 GrantNon-employee Warrant (right to buy) · Derivative 26,420 $7.57 Strike: $19.41 $199,999.40
Disclosure

SEC source: 0001576427-19-000093 · wf-form4_157229316696924.xml · derivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,420

Underlying: Ordinary Shares · 26,420 shares

Expires 2029-10-23

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 17.44 Euros. The U.S. dollar equivalent of the exercise price is $19.41 using the European Central Bank rate as of October 22, 2019 (1.00 = $1.1130), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants.

F4 · price: The subscription price of the non-employee warrant is $7.57. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director.

F2 · derivative.exercise_date: One-fourth of the grant will vest on October 24, 2020 and an additional 1/16th of the grant will vest quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 16:17 UTC Criteo S.A. CRTO · Entity 291 GrantNon-employee Warrant (right to buy) · Derivative 25,000 $7.87 Strike: $22.45 $196,750.00
Disclosure

SEC source: 0001576427-18-000090 · wf-form4_154214382515383.xml · derivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Ordinary Shares · 25,000 shares

Expires 2028-10-25

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants.

F4 · price: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director.

F2 · derivative.exercise_date: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 17:27 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionRestricted Stock Units · Derivative 6,872 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000104 · edgardoc.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,743

Underlying: Common Stock · 6,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
December 07, 2017 Filed Dec 8, 2017 17:27 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionCommon Stock 6,872 $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000104 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,218

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2017 Filed Oct 30, 2017 16:29 UTC Criteo S.A. CRTO · Entity 291 GrantNon-employee Warrant (right to buy) · Derivative 12,225 $16.36 Strike: $42.19 $200,001.00
Disclosure

SEC source: 0001209191-17-058304 · doc4.xml · derivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,225

Underlying: Ordinary Shares · 12,225 shares

Expires 2027-10-26

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785).

F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director.

F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
September 07, 2017 Filed Sep 8, 2017 16:20 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionRestricted Stock Units · Derivative 6,872 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000086 · edgardoc.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,615

Underlying: Common Stock · 6,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
September 07, 2017 Filed Sep 8, 2017 16:20 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionCommon Stock 6,872 $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000086 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2017 Filed Jun 9, 2017 14:38 UTC RADISYS CORP RSYS · Entity 161880 GrantRestricted Stock Units · Derivative 27,487 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000053 · edgardoc.xml · derivative · entry 3

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,487

Underlying: Common Stock · 27,487 shares

Expires not disclosed

F3 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 7, 2017, December 7, 2017, March 7, 2018 and June 7, 2018, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:38 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionRestricted Stock Units · Derivative 4,057 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000053 · edgardoc.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,057 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
June 07, 2017 Filed Jun 9, 2017 14:38 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionCommon Stock 4,057 $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000053 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 17:11 UTC Criteo S.A. CRTO · Entity 291 Exercise / conversionNon-employee Warrant (right to buy) · Derivative 10,000 $0.00 Strike: $9.25 $0.00
Disclosure

SEC source: 0001576427-17-000112 · wf-form4_149669710129617.xml · derivative · entry 3

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,400

Underlying: Ordinary Shares · 10,000 shares

Expires 2022-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $9.25 using the Federal Reserve Bank of New York noon buying rate for May 26, 2017 (1.00 = $1.1170).

F5 · derivative.exercise_date: Warrant granted on October 25, 2012. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
June 02, 2017 Filed Jun 5, 2017 17:11 UTC Criteo S.A. CRTO · Entity 291 SaleOrdinary Shares 10,000 $52.63 $526,300.00
Disclosure

SEC source: 0001576427-17-000112 · wf-form4_149669710129617.xml · nonDerivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.31 to $52.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
June 02, 2017 Filed Jun 5, 2017 17:11 UTC Criteo S.A. CRTO · Entity 291 Exercise / conversionOrdinary Shares 10,000 $9.25 $92,500.00
Disclosure

SEC source: 0001576427-17-000112 · wf-form4_149669710129617.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price of the non-employee warrant is 8.28 euros. The U.S. dollar equivalent of the exercise price is $9.25 using the Federal Reserve Bank of New York noon buying rate for May 26, 2017 (1.00 = $1.1170).

F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").

Read SEC document
March 08, 2017 Filed Mar 9, 2017 17:05 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionRestricted Stock Units · Derivative 4,057 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000021 · edgardoc.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,057

Underlying: Common Stock · 4,057 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
March 08, 2017 Filed Mar 9, 2017 17:05 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionCommon Stock 4,057 $0.00 $0.00
Disclosure

SEC source: 0000873044-17-000021 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 08, 2016 Filed Dec 9, 2016 18:47 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionRestricted Stock Units · Derivative 4,057 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-16-000258 · edgardoc.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,114

Underlying: Common Stock · 4,057 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
December 08, 2016 Filed Dec 9, 2016 18:47 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionCommon Stock 4,057 $0.00 $0.00
Disclosure

SEC source: 0000873044-16-000258 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2016 Filed Nov 4, 2016 14:27 UTC RADISYS CORP RSYS · Entity 161880 PurchaseCommon Stock 7,472 $4.02 $30,037.44
Disclosure

SEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 5

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,303

Read SEC document
November 03, 2016 Filed Nov 4, 2016 14:27 UTC RADISYS CORP RSYS · Entity 161880 PurchaseCommon Stock 1,600 $4.01 $6,416.00
Disclosure

SEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 4

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,831

Read SEC document
November 03, 2016 Filed Nov 4, 2016 14:27 UTC RADISYS CORP RSYS · Entity 161880 PurchaseCommon Stock 100 $4.00 $400.00
Disclosure

SEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 3

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,231

Read SEC document
November 03, 2016 Filed Nov 4, 2016 14:27 UTC RADISYS CORP RSYS · Entity 161880 PurchaseCommon Stock 100 $3.99 $399.00
Disclosure

SEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,131

Read SEC document
November 03, 2016 Filed Nov 4, 2016 14:27 UTC RADISYS CORP RSYS · Entity 161880 PurchaseCommon Stock 728 $3.98 $2,897.44
Disclosure

SEC source: 0000873044-16-000253 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,031

Read SEC document
October 27, 2016 Filed Oct 28, 2016 16:17 UTC Criteo S.A. CRTO · Entity 291 GrantNon-employee Warrant (right to buy) · Derivative 13,185 $0.00 Strike: $36.92 $0.00
Disclosure

SEC source: 0001576427-16-000382 · wf-form4_147768584935680.xml · derivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,185

Underlying: Ordinary Shares · 13,185 shares

Expires 2026-10-27

F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866).

F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.

F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Read SEC document
September 08, 2016 Filed Sep 9, 2016 16:40 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionRestricted Stock Units · Derivative 4,057 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000873044-16-000233 · edgardoc.xml · derivative · entry 2

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,171

Underlying: Common Stock · 4,057 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Restricted stock units vest 25% of the total shares on each of the following dates: September 8, 2016, December 8, 2016, March 8, 2017 and June 8, 2017, provided that grants will vest in full on the first anniversary of the date of grant or immediately prior to the next regular annual shareholder meeting following the date of grant if the shareholder meeting occurs prior to the first anniversary date of the date of grant. One share of Common Stock will be automatically delivered to the reporting person for each restricted stock unit that vests.

F2 · derivative.expiration_date: N/A

Read SEC document
September 08, 2016 Filed Sep 9, 2016 16:40 UTC RADISYS CORP RSYS · Entity 161880 Exercise / conversionCommon Stock 4,057 $0.00 $0.00
Disclosure

SEC source: 0000873044-16-000233 · edgardoc.xml · nonDerivative · entry 1

de Pesquidoux Hubert · CIK 0001464176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,303

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.